209 related articles for article (PubMed ID: 32006198)
1. DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation.
Yang Z; Zhu H; Zhang L; Wei Q; Zhou L; Xu X; Song P; Liu J; Xie H; Zheng S
Mol Biol Rep; 2020 Mar; 47(3):1773-1782. PubMed ID: 32006198
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.
Wu LM; Zhang F; Zhou L; Yang Z; Xie HY; Zheng SS
BMC Cancer; 2010 Aug; 10():399. PubMed ID: 20678188
[TBL] [Abstract][Full Text] [Related]
4. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
Liu M; Cui LH; Li CC; Zhang L
Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
[TBL] [Abstract][Full Text] [Related]
5. Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients.
Jiang BG; Wang N; Huang J; Yang Y; Sun LL; Pan ZY; Zhou WP
Oncotarget; 2017 Apr; 8(17):28621-28627. PubMed ID: 28404963
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
[TBL] [Abstract][Full Text] [Related]
7. Methylation site
Yang Z; Chen W; Zhu H; Zhang L; Zhou K; Tang H; Sun R; Huang Y; Xie H; Zheng S; Jia C
Future Oncol; 2022 Jun; 18(19):2401-2413. PubMed ID: 35502765
[No Abstract] [Full Text] [Related]
8. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
Sasi W; Jiang WG; Sharma A; Mokbel K
BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients.
Saelee P; Chuensumran U; Wongkham S; Chariyalertsak S; Tiwawech D; Petmitr S
Asian Pac J Cancer Prev; 2012; 13(7):3489-93. PubMed ID: 22994783
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
Qiu X; Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
Mol Cell Biochem; 2013 Jun; 378(1-2):99-106. PubMed ID: 23475171
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
13. Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.
Wei L; Huang Y; Zhao R; Zhang J; Liu Q; Liang W; Ding X; Gao B; Li B; Sun C; He J; Yu X; Liu Z; Sun A; Qin Y
Clin Exp Med; 2018 Feb; 18(1):79-87. PubMed ID: 28951980
[TBL] [Abstract][Full Text] [Related]
14. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
16. An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.
Zhang X; Wang J; Cheng J; Ding S; Li M; Sun S; Zhang L; Liu S; Chen X; Zhuang H; Lu F
J Viral Hepat; 2014 Apr; 21(4):264-71. PubMed ID: 23941364
[TBL] [Abstract][Full Text] [Related]
17. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
Zhang MY; Fung TK; Chen FY; Chim CS
J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
[TBL] [Abstract][Full Text] [Related]
18. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
Zhang X; You Q; Zhang X; Chen X
Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582
[TBL] [Abstract][Full Text] [Related]
19. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.
Al-Ameri AAM; Wei X; Liu P; Lin L; Shao Z; Xie H; Zhou L; Zheng S; Xu X
Ann Transplant; 2019 Aug; 24():489-498. PubMed ID: 31427563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
